Adaptive Biotechnologies Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Adaptive Biotechnologies Corp.
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
/ 
Frequently asked questions
To buy Adaptive Biotechnologies Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Adaptive Biotechnologies Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Adaptive Biotechnologies Corp. is ADPT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Adaptive Biotechnologies Corp. has its primary listing on NASDAQ. You can trade Adaptive Biotechnologies Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Adaptive Biotechnologies Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Adaptive Biotechnologies Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Adaptive Biotechnologies Corp..